{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:19:00Z","timestamp":1794327540480,"version":"4.9.0"},"reference-count":102,"publisher":"American Medical Association (AMA)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2024,12,17]]},"abstract":"\n Importance<\/jats:title>\n Calcific aortic stenosis (AS) restricts the aortic valve opening during systole due to calcification and fibrosis of either a congenital bicuspid or a normal trileaflet aortic valve. In the US, AS affects 1% to 2% of adults older than 65 years and approximately 12% of adults older than 75 years. Worldwide, AS leads to more than 100\u202f000 deaths annually.<\/jats:p>\n <\/jats:sec>\n \n Observations<\/jats:title>\n \n Calcific AS is characterized by aortic valve leaflet lipid infiltration and inflammation with subsequent fibrosis and calcification. Symptoms due to severe AS, such as exercise intolerance, exertional dyspnea, and syncope, are associated with a 1-year mortality rate of up to 50% without aortic valve replacement. Echocardiography can detect AS and measure the severity of aortic valve dysfunction. Although progression rates vary, once aortic velocity is higher than 2 m\/s, progression to severe AS occurs typically within 10 years. Severe AS is defined by an aortic velocity 4 m\/s or higher, a mean gradient 40 mm Hg or higher, or a valve area less than or equal to 1.0 cm\n 2<\/jats:sup>\n . Management of mild to moderate AS and asymptomatic severe AS consists of patient education about the typical progression of disease; clinical and echocardiographic surveillance at intervals of 3 to 5 years for mild AS, 1 to 2 years for moderate AS, and 6 to 12 months for severe AS; and treatment of hypertension, hyperlipidemia, and cigarette smoking as indicated. When a patient with severe AS develops symptoms, surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) is recommended, which restores an average life expectancy; in patients aged older than 70 years with a low surgical risk, 10-year all-cause mortality was 62.7% with TAVI and 64.0% with SAVR. TAVI is associated with decreased length of hospitalization, more rapid return to normal activities, and less pain compared with SAVR. However, evidence supporting TAVI for patients aged younger than 65 years and long-term outcomes of TAVI are less well defined than for SAVR. For patients with symptomatic severe AS, the 2020 American College of Cardiology\/American Heart Association guideline recommends SAVR for individuals aged 65 years and younger, SAVR or TAVI for those aged 66 to 79 years, and TAVI for individuals aged 80 years and older or those with an estimated surgical mortality of 8% or higher.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Calcific AS is a common chronic progressive condition among older adults and is diagnosed via echocardiography. Symptomatic patients with severe AS have a mortality rate of up to 50% after 1 year, but treatment with SAVR or TAVI reduces mortality to that of age-matched control patients. The type and timing of valve replacement should be built on evidence-based guidelines, shared decision-making, and involvement of a multidisciplinary heart valve team.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jama.2024.16477","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T11:00:38Z","timestamp":1731322838000},"page":"2014","source":"Crossref","is-referenced-by-count":113,"title":["Calcific Aortic Stenosis"],"prefix":"10.1001","volume":"332","author":[{"given":"Catherine M.","family":"Otto","sequence":"first","affiliation":[{"name":"Division of Cardiology, University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Newby","sequence":"additional","affiliation":[{"name":"University of Edinburgh, British Heart Foundation Centre of Research Excellence, Royal Infirmary, Edinburgh, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham S.","family":"Hillis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Royal Perth Hospital and Medical School, University of Western Australia, Perth"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"jrv240022r1","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990-2015.","volume":"377","author":"Watkins","year":"2017","journal-title":"N Engl J Med"},{"issue":"22","key":"jrv240022r2","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1136\/heartjnl-2018-313082","article-title":"Cardiac auscultation poorly predicts the presence of valvular heart disease in asymptomatic primary care patients.","volume":"104","author":"Gardezi","year":"2018","journal-title":"Heart"},{"issue":"2","key":"jrv240022r3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1053\/hj.1999.v137.95496","article-title":"Physical examination in valvular aortic stenosis: correlation with stenosis severity and prediction of clinical outcome.","volume":"137","author":"Munt","year":"1999","journal-title":"Am Heart J"},{"issue":"4","key":"jrv240022r4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/heartjnl-2018-313593","article-title":"Integration of echocardiographic screening by non-physicians with remote reading in primary care.","volume":"105","author":"Nascimento","year":"2019","journal-title":"Heart"},{"issue":"17","key":"jrv240022r5","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.","volume":"363","author":"Leon","year":"2010","journal-title":"N Engl J Med"},{"issue":"21","key":"jrv240022r6","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1161\/CIRCULATIONAHA.119.043391","article-title":"Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990-2017.","volume":"141","author":"Yadgir","year":"2020","journal-title":"Circulation"},{"key":"jrv240022r7","doi-asserted-by":"publisher","first-page":"16006","DOI":"10.1038\/nrdp.2016.6","article-title":"Calcific aortic stenosis.","volume":"2","author":"Lindman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"18","key":"jrv240022r8","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1136\/heartjnl-2021-319025","article-title":"Cumulative burden of clinically significant aortic stenosis in community-dwelling older adults.","volume":"107","author":"Owens","year":"2021","journal-title":"Heart"},{"issue":"47","key":"jrv240022r9","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1093\/eurheartj\/ehw229","article-title":"Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people.","volume":"37","author":"d\u2019Arcy","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"jrv240022r10","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.athoracsur.2022.12.033","article-title":"The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2022 update on outcomes and research.","volume":"115","author":"Kim","year":"2023","journal-title":"Ann Thorac Surg"},{"issue":"10","key":"jrv240022r11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.acvd.2023.07.008","article-title":"Independent association of aortic stenosis with many known cardiovascular risk factors and many inflammatory diseases.","volume":"116","author":"Movahed","year":"2023","journal-title":"Arch Cardiovasc Dis"},{"issue":"12","key":"jrv240022r12","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s41569-021-00570-z","article-title":"Global epidemiology of valvular heart disease.","volume":"18","author":"Coffey","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"jrv240022r13","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1001\/jamacardio.2019.3903","article-title":"Association of low-density lipoprotein cholesterol with risk of aortic valve stenosis in familial hypercholesterolemia.","volume":"4","author":"Mundal","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"4","key":"jrv240022r14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1001\/jamacardio.2023.5597","article-title":"Sex differences in diagnosis, treatment, and cardiovascular outcomes in homozygous familial hypercholesterolemia.","volume":"9","author":"Mulder","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"3","key":"jrv240022r15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ymgme.2021.05.007","article-title":"Evaluating the aortic stenosis phenotype before and after the effect of homogentisic acid lowering therapy: analysis of a large cohort of eighty-one alkaptonuria patients.","volume":"133","author":"Ranganath","year":"2021","journal-title":"Mol Genet Metab"},{"issue":"1","key":"jrv240022r16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-024-00498-x","article-title":"Alkaptonuria.","volume":"10","author":"Bernardini","year":"2024","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"jrv240022r17","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/01.CIR.0000155623.48408.C5","article-title":"Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation.","volume":"111","author":"Roberts","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"jrv240022r18","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jacc.2015.05.066","article-title":"Calcification in aortic stenosis: the skeleton key.","volume":"66","author":"Pawade","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"jrv240022r19","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1161\/ATVBAHA.119.313067","article-title":"Aortic valve stenosis: from basic mechanisms to novel therapeutic targets.","volume":"40","author":"Goody","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"jrv240022r20","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001254","article-title":"Unraveling the mechanisms of valvular heart disease to identify medical therapy targets.","author":"Small","year":"2024","journal-title":"Circulation"},{"key":"jrv240022r21","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1016\/j.jacc.2014.04.018","article-title":"The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis.","volume":"63","author":"Coffey","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"jrv240022r22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/heartjnl-2023-322709","article-title":"Traditional and novel risk factors for incident aortic stenosis in community-dwelling older adults.","volume":"110","author":"Massera","year":"2023","journal-title":"Heart"},{"issue":"40","key":"jrv240022r23","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1093\/eurheartj\/ehaa070","article-title":"Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study.","volume":"41","author":"Nazarzadeh","year":"2020","journal-title":"Eur Heart J"},{"issue":"39","key":"jrv240022r24","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1093\/eurheartj\/ehy486","article-title":"Elevated blood pressure and risk of aortic valve disease: a cohort analysis of 5.4 million UK adults.","volume":"39","author":"Rahimi","year":"2018","journal-title":"Eur Heart J"},{"issue":"5","key":"jrv240022r25","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1161\/CIR.0000000000000923","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"issue":"3","key":"jrv240022r26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jcmg.2022.10.009","article-title":"Aortic stenosis progression: a systematic review and meta-analysis.","volume":"16","author":"Willner","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"issue":"13","key":"jrv240022r27","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.","volume":"359","author":"Rosseb\u00f8","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"jrv240022r28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the Aortic Stenosis Progression Observation.","volume":"121","author":"Chan","year":"2010","journal-title":"Circulation"},{"issue":"43","key":"jrv240022r29","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1093\/eurheartj\/ehad477","article-title":"Bicuspid aortic valve: long-term morbidity and mortality.","volume":"44","author":"Yang","year":"2023","journal-title":"Eur Heart J"},{"issue":"21","key":"jrv240022r30","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1136\/heartjnl-2023-322859","article-title":"Recurrence of syncope after valve replacement in severe aortic stenosis.","volume":"109","author":"San Rom\u00e1n","year":"2023","journal-title":"Heart"},{"issue":"6","key":"jrv240022r31","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.amjcard.2018.12.009","article-title":"Relation of clinical presentation of aortic stenosis and survival following transcatheter aortic valve implantation.","volume":"123","author":"Ben-Shoshan","year":"2019","journal-title":"Am J Cardiol"},{"issue":"3","key":"jrv240022r32","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.mayocp.2023.09.024","article-title":"Evolution and prognostic significance of patient-reported symptoms after intervention in severe aortic stenosis.","volume":"99","author":"San Rom\u00e1n","year":"2024","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"jrv240022r33","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/heartjnl-2018-313746","article-title":"B-type natriuretic peptide in patients with asymptomatic severe aortic stenosis.","volume":"105","author":"Nakatsuma","year":"2019","journal-title":"Heart"},{"issue":"4","key":"jrv240022r34","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.echo.2017.02.009","article-title":"Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography.","volume":"30","author":"Baumgartner","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"issue":"17","key":"jrv240022r35","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/heartjnl-2022-321660","article-title":"Computed tomographic imaging of patients with native and prosthetic aortic valve stenosis.","volume":"109","author":"Geers","year":"2023","journal-title":"Heart"},{"issue":"7","key":"jrv240022r36","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease.","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"issue":"6","key":"jrv240022r37","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.122.009712","article-title":"Target aortic stenosis: a national initiative to improve quality of care and outcomes for patients with aortic stenosis.","volume":"16","author":"Lindman","year":"2023","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"jrv240022r38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/ehjci\/jew013","article-title":"Systolic hypertension and progression of aortic valve calcification in patients with aortic stenosis.","volume":"18","author":"Tastet","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"12","key":"jrv240022r39","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1111\/eci.12169","article-title":"Impact of hypertension and renin-angiotensin system inhibitors in aortic stenosis.","volume":"43","author":"Capoulade","year":"2013","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"jrv240022r40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/HYPERTENSIONAHA.112.194878","article-title":"Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events.","volume":"60","author":"Rieck","year":"2012","journal-title":"Hypertension"},{"issue":"6","key":"jrv240022r41","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jacc.2011.01.063","article-title":"Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis.","volume":"58","author":"Nadir","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"jrv240022r42","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ahj.2013.11.002","article-title":"Short-term hemodynamic effect of angiotensin-converting enzyme inhibition in patients with severe aortic stenosis.","volume":"167","author":"Dalsgaard","year":"2014","journal-title":"Am Heart J"},{"issue":"8","key":"jrv240022r43","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/ehjci\/jev043","article-title":"A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial).","volume":"16","author":"Bull","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"jrv240022r44","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3109\/08037051.2013.858482","article-title":"Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment (the LIFE study).","volume":"23","author":"Mancusi","year":"2014","journal-title":"Blood Press"},{"issue":"3","key":"jrv240022r45","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ijcard.2014.06.013","article-title":"Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.","volume":"175","author":"Bang","year":"2014","journal-title":"Int J Cardiol"},{"key":"jrv240022r46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijcard.2015.04.083","article-title":"Beta-blockers can improve survival in medically-treated patients with severe symptomatic aortic stenosis.","volume":"190","author":"Rossi","year":"2015","journal-title":"Int J Cardiol"},{"issue":"10","key":"jrv240022r47","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.117.006557","article-title":"Metoprolol reduces hemodynamic and metabolic overload in asymptomatic aortic valve stenosis patients: a randomized trial.","volume":"10","author":"Hansson","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"issue":"12","key":"jrv240022r48","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006709","article-title":"Antihypertensive treatment with \u00df-blockade in patients with asymptomatic aortic stenosis and association with cardiovascular events.","volume":"6","author":"Bang","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"17","key":"jrv240022r49","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/eurheartj\/ehy629","article-title":"Incidence of infective endocarditis in patients considered at moderate risk.","volume":"40","author":"\u00d8stergaard","year":"2019","journal-title":"Eur Heart J"},{"issue":"22","key":"jrv240022r50","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/j.jacc.2012.02.029","article-title":"Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications.","volume":"59","author":"Duval","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"jrv240022r51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2003.10.017","article-title":"Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS).","volume":"147","author":"Chockalingam","year":"2004","journal-title":"Am Heart J"},{"issue":"23","key":"jrv240022r52","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.","volume":"352","author":"Cowell","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"jrv240022r53","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.amjcard.2008.04.060","article-title":"Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg).","volume":"102","author":"Dichtl","year":"2008","journal-title":"Am J Cardiol"},{"issue":"2","key":"jrv240022r54","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.amjcard.2011.03.032","article-title":"Effects of rosuvastatin on progression of stenosis in adult patients with congenital aortic stenosis (PROCAS Trial).","volume":"108","author":"van der Linde","year":"2011","journal-title":"Am J Cardiol"},{"issue":"25","key":"jrv240022r55","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.121.053708","article-title":"Effect of denosumab or alendronic acid on the progression of aortic stenosis: a double-blind randomized controlled trial.","volume":"143","author":"Pawade","year":"2021","journal-title":"Circulation"},{"issue":"21","key":"jrv240022r56","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1161\/CIRCULATIONAHA.116.027011","article-title":"Slower progress of aortic valve calcification with vitamin K supplementation.","volume":"135","author":"Brandenburg","year":"2017","journal-title":"Circulation"},{"issue":"18","key":"jrv240022r57","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.121.057008","article-title":"Vitamin K2 and D in patients with aortic valve calcification: a randomized double-blinded clinical trial.","volume":"145","author":"Diederichsen","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"jrv240022r58","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ahj.2008.03.012","article-title":"A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis.","volume":"156","author":"Stewart","year":"2008","journal-title":"Am Heart J"},{"issue":"3","key":"jrv240022r59","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/FJC.0000000000000182","article-title":"Is blockade of the renin-angiotensin system able to reverse the structural and functional remodeling of the left ventricle in severe aortic stenosis?","volume":"65","author":"Helske-Suihko","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"issue":"6","key":"jrv240022r60","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis.","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N Engl J Med"},{"issue":"17","key":"jrv240022r61","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.jacc.2019.01.070","article-title":"Lipoprotein(a) and oxidized phospholipids promote valve calcification in patients with aortic stenosis.","volume":"73","author":"Zheng","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"jrv240022r62","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1136\/heartjnl-2021-319044","article-title":"Lipoprotein(a) is robustly associated with aortic valve calcium.","volume":"107","author":"Kaiser","year":"2021","journal-title":"Heart"},{"issue":"20","key":"jrv240022r63","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1016\/j.jacc.2018.10.007","article-title":"2019 AATS\/ACC\/ASE\/SCAI\/STS expert consensus systems of care document: a proposal to optimize care for patients with valvular heart disease: a joint report of the American Association for Thoracic Surgery, American College of Cardiology, American Society of Echocardiography, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.","volume":"73","author":"Nishimura","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"jrv240022r64","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.jacc.2021.11.060","article-title":"Trends in utilization of aortic valve replacement for severe aortic stenosis.","volume":"79","author":"Li","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"jrv240022r65","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ahj.2023.11.019","article-title":"Design and rationale of the evaluation of transcatheter aortic valve replacement compared to surveillance for patients with asymptomatic severe aortic stenosis.","volume":"268","author":"G\u00e9n\u00e9reux","year":"2024","journal-title":"Am Heart J"},{"issue":"24","key":"jrv240022r66","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1161\/CIRCULATIONAHA.104.495903","article-title":"Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up.","volume":"111","author":"Pellikka","year":"2005","journal-title":"Circulation"},{"issue":"45","key":"jrv240022r67","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1093\/eurheartj\/ehaa485","article-title":"Timing of intervention in asymptomatic patients with valvular heart disease.","volume":"41","author":"Baumgartner","year":"2020","journal-title":"Eur Heart J"},{"issue":"12","key":"jrv240022r68","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.121.058598","article-title":"Is asymptomatic severe aortic stenosis still a waiting game?","volume":"145","author":"Hillis","year":"2022","journal-title":"Circulation"},{"issue":"2 Pt 1","key":"jrv240022r69","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jcmg.2019.01.036","article-title":"Management of asymptomatic severe aortic stenosis: evolving concepts in timing of valve replacement.","volume":"13","author":"Lindman","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"18","key":"jrv240022r70","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1161\/CIRCULATIONAHA.117.032839","article-title":"Myocardial scar and mortality in severe aortic stenosis.","volume":"138","author":"Musa","year":"2018","journal-title":"Circulation"},{"issue":"19","key":"jrv240022r71","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.jacc.2012.02.093","article-title":"Calcific aortic stenosis: a disease of the valve and the myocardium.","volume":"60","author":"Dweck","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"jrv240022r72","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1016\/j.jacc.2015.10.001","article-title":"Initial surgical versus conservative strategies in patients with asymptomatic severe aortic stenosis.","volume":"66","author":"Taniguchi","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"jrv240022r73","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1912846","article-title":"Early surgery or conservative care for asymptomatic aortic stenosis.","volume":"382","author":"Kang","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"jrv240022r74","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1161\/CIRCULATIONAHA.121.057639","article-title":"Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: the AVATAR trial.","volume":"145","author":"Banovic","year":"2022","journal-title":"Circulation"},{"issue":"8","key":"jrv240022r75","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jamacardio.2023.1459","article-title":"Implementing shared decision-making for patients with aortic stenosis with longer life expectancy.","volume":"8","author":"Coylewright","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"13","key":"jrv240022r76","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves.","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"issue":"23","key":"jrv240022r77","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients.","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"jrv240022r78","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1056\/NEJMc1408396","article-title":"Transcatheter aortic-valve replacement with a self-expanding prosthesis.","volume":"371","author":"Adams","year":"2014","journal-title":"N Engl J Med"},{"issue":"14","key":"jrv240022r79","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients.","volume":"376","author":"Reardon","year":"2017","journal-title":"N Engl J Med"},{"issue":"17","key":"jrv240022r80","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients.","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"jrv240022r81","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1093\/eurheartj\/ehac642","article-title":"Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials.","volume":"44","author":"Ahmad","year":"2023","journal-title":"Eur Heart J"},{"issue":"20","key":"jrv240022r82","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/j.jacc.2015.03.014","article-title":"Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the All-Comers NOTION randomized clinical trial.","volume":"65","author":"Thyregod","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"jrv240022r83","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients.","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"issue":"18","key":"jrv240022r84","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients.","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"issue":"19","key":"jrv240022r85","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1001\/jama.2022.5776","article-title":"Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis: a randomized clinical trial.","volume":"327","author":"Toff","year":"2022","journal-title":"JAMA"},{"issue":"12","key":"jrv240022r86","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-054222","article-title":"Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis.","volume":"11","author":"Swift","year":"2021","journal-title":"BMJ Open"},{"issue":"3","key":"jrv240022r87","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1161\/CIRCULATIONAHA.120.051456","article-title":"Composite metric for benchmarking site performance in transcatheter aortic valve replacement: results from the STS\/ACC TVT Registry.","volume":"144","author":"Desai","year":"2021","journal-title":"Circulation"},{"key":"jrv240022r88","doi-asserted-by":"publisher","first-page":"i5065","DOI":"10.1136\/bmj.i5065","article-title":"Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies.","volume":"354","author":"Foroutan","year":"2016","journal-title":"BMJ"},{"issue":"45","key":"jrv240022r89","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1093\/eurheartj\/ehx199","article-title":"Mechanical aortic valve replacement in non-elderly adults: meta-analysis and microsimulation.","volume":"38","author":"Korteland","year":"2017","journal-title":"Eur Heart J"},{"issue":"13","key":"jrv240022r90","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1093\/eurheartj\/ehae043","article-title":"Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.","volume":"45","author":"Thyregod","year":"2024","journal-title":"Eur Heart J"},{"issue":"22","key":"jrv240022r91","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1136\/heartjnl-2017-312348","article-title":"Importance of the valve durability-life expectancy ratio in selection of a prosthetic aortic valve.","volume":"103","author":"Bagur","year":"2017","journal-title":"Heart"},{"issue":"30","key":"jrv240022r92","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1093\/eurheartj\/ehab393","article-title":"Transcatheter aortic valve implantation or replacement? Valve durability in the context of patient life expectancy.","volume":"42","author":"Oyetunji","year":"2021","journal-title":"Eur Heart J"},{"key":"jrv240022r93","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2022.31","article-title":"Treatment of severe aortic valve stenosis: impact of patient sex and life expectancy on treatment choice.","volume":"17","author":"Rashedi","year":"2022","journal-title":"Eur Cardiol"},{"issue":"3","key":"jrv240022r94","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.athoracsur.2015.03.105","article-title":"Very long-term outcomes of the Carpentier-Edwards Perimount aortic valve in patients aged 60 or younger.","volume":"100","author":"Bourguignon","year":"2015","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"jrv240022r95","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jacc.2023.04.049","article-title":"Outcomes of SAPIEN 3 transcatheter aortic valve replacement compared with surgical valve replacement in intermediate-risk patients.","volume":"82","author":"Madhavan","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"jrv240022r96","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.athoracsur.2015.04.062","article-title":"Contemporary outcomes of repeat aortic valve replacement: a benchmark for transcatheter valve-in-valve procedures.","volume":"100","author":"Kaneko","year":"2015","journal-title":"Ann Thorac Surg"},{"issue":"24","key":"jrv240022r97","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024848","article-title":"Valve-in-valve transcatheter aortic valve replacement versus redo surgical aortic valve replacement for failed surgical aortic bioprostheses: a systematic review and meta-analysis.","volume":"11","author":"Raschpichler","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"jrv240022r98","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59398","article-title":"Clinical profiles and outcomes of prosthesis-specific infective endocarditis subsequent to transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis.","volume":"16","author":"Monaci","year":"2024","journal-title":"Cureus"},{"issue":"20","key":"jrv240022r99","doi-asserted-by":"publisher","first-page":"e963","DOI":"10.1161\/CIR.0000000000000969","article-title":"Prevention of viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association.","volume":"143","author":"Wilson","year":"2021","journal-title":"Circulation"},{"issue":"6","key":"jrv240022r100","doi-asserted-by":"publisher","first-page":"739","DOI":"10.14219\/jada.archive.2007.0262","article-title":"Prevention of infective endocarditis: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.","volume":"138","author":"Wilson","year":"2007","journal-title":"J Am Dent Assoc"},{"issue":"8","key":"jrv240022r101","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/jocs.13183","article-title":"Heterogeneity of systolic dysfunction in patients with severe aortic stenosis and preserved ejection fraction.","volume":"32","author":"Lindman","year":"2017","journal-title":"J Card Surg"},{"issue":"38","key":"jrv240022r102","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1093\/eurheartj\/ehz275","article-title":"Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis.","volume":"40","author":"Siontis","year":"2019","journal-title":"Eur Heart J"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2826117\/jama_otto_2024_rv_240022_1733431184.46484.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T11:02:14Z","timestamp":1734433334000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2826117"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":102,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2024,12,17]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2024.16477","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,17]]}}}